Nephrocare trading window closed from June 22 until Q1FY27 results
Nephrocare Health Services Ltd has closed its trading window for designated persons effective June 22, 2026, due to unpublished price sensitive information including Q1FY27 results. The window will reopen 48 hours after the unaudited financial results for the quarter ended June 30, 2026 are declared, in compliance with SEBI regulations.

*this image is generated using AI for illustrative purposes only.
Nephrocare Health Services Ltd has closed its trading window for designated persons and their immediate relatives effective June 22, 2026, due to the existence of unpublished price sensitive information. The closure encompasses the financial results of the company for the quarter ending June 30, 2026. The trading window will remain closed until 48 hours after the declaration of the unaudited financial results for the quarter ended June 30, 2026.
The decision is in accordance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, and the company's Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons and their Immediate Relatives. This measure ensures compliance with regulatory standards to prevent insider trading during the period of financial result finalization.
Key Dates and Details
| Event | Date |
|---|---|
| Trading Window Closure | June 22, 2026 |
| Quarter End | June 30, 2026 |
| Window Reopens | 48 hours after Q1FY27 results declaration |
The intimation regarding the closure has been made available on the company's official website. Kishore Kathri, the Company Secretary & Compliance Officer, signed the disclosure on June 19, 2026.
Historical Stock Returns for Nephrocare Health Services
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.20% | +9.70% | +4.80% | +34.75% | +46.38% | +46.38% |
How might the upcoming Q1FY27 results impact Nephrocare's stock performance once the trading window reopens?
What strategic initiatives or operational changes contributed to the unpublished price-sensitive information?
How will investors react to the financial results given the extended trading window closure?


































